Cambridge Healthtech Institute’s 12th Annual

Clinical Data Strategy and Analytics

Enabling Data Driven Clinical Trials

February 19-20, 2020


E-clinical technologies have changed the landscape of the clinical research industry and healthcare IT in general. Digitalization of healthcare data, mobile data capture technologies, and cloud storage of data are a few of the main technological advances that influence clinical data management and analytics. These technological advances have been coupled with novel data visualization solutions, and this powerful duo is helping to develop a new paradigm of data-driven clinical trials. CHI’s 12th Annual Clinical Data Strategy and Analytics conference will be bringing together top clinical research informatics experts to discuss the challenges and find solutions necessary to navigate and thrive in the rapidly changing environment.

Stay on and attend Part 2 (Thurs-Fri): Artificial Intelligence in Clinical Research

Preliminary Agenda

KEYNOTE SESSION

Modern Clinical Data Concepts – Models, Technology and Regulations

Brooks Fowler, Senior Director and Global Head, Data Science, AbbVie

Talk Title to be Announced

Joe Mather, Executive Director, Head of Advanced Science and Collaboration Group, Pfizer

Opportunities to Apply AI in the Clinical Data Environment

Demetris Zambas, Vice President and Global Head, Data Monitoring and Management, Pfizer

Digital Biomarkers: An Intersection of Clinical Research, Engineering and Data Sciences

Sina Djali, Head, Clinical and Operations Analytics, Johnson & Johnson

Reimagining Clinical Data Operations

Dermot Kenny, Global Head, Data Operations, Novartis

DATA DEPARTMENTS TO ADJUST TO DIGITALIZATION OF CLINICAL TRIALS

Need to Un-Scale the Clinical Data and Analytics Operating Model in Order to Scale Digital Health

Nareen Katta, Head, Clinical Analytics, AbbVie

CASE STUDY: DMD Phase II and Phase III Study Lessons Learned with Various eData Collection

Susan Bornstein, MPH, Senior Director, Data Monitoring and Data Management, Global Product Development, Pfizer

The Evolution of Real-World Data Capture and Application

Steven Draikiwicz, MD, Global Medical Bioinformatics Lead, Sanofi

CO-PRESENTATION: Real-World Data Strategy in Accelerating Clinical Trial and Research

Xia Wang, PhD, Director, Health Informatics & Global Medicines Development, AstraZeneca
Jane Fang, MD, Head, Clinical Business Management & Analytics, MEDI Biologics Unit, AstraZeneca

ADVANCED ANALYTICS TO RESHAPE CLINICAL OPERATIONS

The Curve Ahead: Dynamics of Clinical Trial Recruitment Projections

Ozgur Ozkan, IT Director, Clinical Decision Support, The Janssen Pharmaceutical Companies of Johnson & Johnson

Case Studies on a Process to Streamline Clinical Protocols

Michael Dawson, Director, Development Design Center, AbbVie

Quality Risk Management Framework: Guidance for Successful Implementation of Risk Management in Clinical Development

Jonathan Rowe, PhD, Executive Director & Head, Quality Performance and Risk Management, Pfizer

PLENARY KEYNOTES

Tuesday Evening, Wednesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:

SCOPE’s 2020 Participant Engagement Award, in Memory of Jerry Matczak
Patient Perspectives as an Input to Feasibility and Clinical Trial Design
Digital Trends that Are Changing Clinical Research
Health Literacy Throughout Drug Development – Why It Matters to Pharma and to Patients
Implementing an Innovation Methodology to Accelerate Clinical Trial Innovation within Your Organization

For more details on the Plenary Keynotes: www.scopesummit.com/keynotes
For more details on the Participant Engagement Award: www.scopesummit.com/participant-engagement-award

INTERACTIVE BREAKOUT DISCUSSION GROUPS

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing: www.scopesummit.com/breakouts

 

Stay on and attend Part 2 (Thurs-Fri): Artificial Intelligence in Clinical Research




For more details on the conference, please contact:
Marina Fishtinsky, MD

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781.972.5496

Email: mfilshtinsky@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Ilana Quigley

Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.5457

Email: iquigley@healthtech.com

 

Companies L-Z

Patty Rose
Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.1349
Email: prose@healthtech.com